Disentangling on and off-target binding in flortaucipir PET: a voxel-to-voxel P-tau, ferric iron, and MAO-B histology-to-flortaucipir PET comparison - Summary - MDSpire

Disentangling on and off-target binding in flortaucipir PET: a voxel-to-voxel P-tau, ferric iron, and MAO-B histology-to-flortaucipir PET comparison

  • By

  • Yuheng Chen

  • Renaud La Joie

  • Felipe L. Pereira

  • Ganna Blazhenets

  • Lucile Zhu

  • Salvatore Spina

  • William W. Seeley

  • Helmut Heinsen

  • Daniela Ushizima

  • Duygu Tosun

  • Gil D. Rabinovici

  • Lea T. Grinberg

  • February 25, 2026

  • 0 min

Share

Objective:

To investigate the contributions of phospho-tau, ferric iron, and MAO-B to the Flortaucipir PET signal in various neurodegenerative disorders, emphasizing the importance of understanding off-target binding.

Key Findings:
  • Flortaucipir shows off-target retention in regions not expected to have significant tau pathology, particularly in non-Alzheimer's tauopathies, indicating potential misinterpretation of PET results.
  • Colocalization of Flortaucipir uptake with ferric iron accumulation suggests non-tau-related binding, complicating the understanding of imaging results.
  • MAO-B may contribute to off-target signals, but evidence remains conflicting regarding its impact on Flortaucipir binding, necessitating further investigation.
Interpretation:

The findings indicate that Flortaucipir PET signals may reflect a combination of tau and non-tau substrates, complicating the interpretation of imaging results in neurodegenerative diseases and highlighting the need for careful clinical assessment.

Limitations:
  • Small sample size of five subjects limits generalizability.
  • Confounding factors such as the presence of multiple neurodegenerative pathologies may affect results.
  • Potential biases in post-mortem studies could influence findings.
Conclusion:

Understanding the neurobiological basis of Flortaucipir signals is crucial for improving diagnostic accuracy and monitoring disease progression in neurodegenerative disorders.

Original Source(s)

Related Content